(ABEV) Ambev - Ratings and Ratios
Beer, Soft Drink, Water, Energy Drink, Juice
ABEV EPS (Earnings per Share)
ABEV Revenue
Description: ABEV Ambev
Ambev S.A., through its subsidiaries, produces, distributes, and sells a broad portfolio of alcoholic and non-alcoholic beverages-including beer, draft beer, carbonated soft drinks, malt-based drinks, bottled water, energy drinks, and ready-to-drink teas-across Brazil, Central America, the Caribbean, Latin America South, and Canada.
The company markets its products under flagship owned brands such as Brahma, Antarctica, Quilmes, and Presidente, and also carries licensed international labels including Budweiser, Corona, Stella Artois, and Red Bull, reaching consumers via both a direct-distribution network and a network of third-party distributors.
Founded in 1885 and headquartered in São Paulo, Brazil, Ambev operates as a subsidiary of Interbrew International B.V., the European arm of Anheuser-Busch InBev, and is listed on the NYSE under the ticker ABEV.
Key recent metrics: 2023 net revenue reached US$ 15.9 billion, reflecting a 7 % year-over-year increase driven by volume growth in Brazil’s premium-segment beers; EBITDA margin held steady at 23 %; and the company’s market share in Brazil’s beer market remains above 60 %, giving it pricing power in a region where consumer spending is sensitive to real-exchange-rate fluctuations and commodity input costs (e.g., barley, aluminum). Additionally, Ambev’s aggressive rollout of low- and no-sugar soft-drink variants aligns with the broader Latin-American health-trend, which is expected to lift non-beer category growth by 3-4 % annually.
For a deeper, data-driven assessment of Ambev’s valuation dynamics and scenario analysis, you may find the analytics on ValueRay worth exploring.
ABEV Stock Overview
Market Cap in USD | 34,233m |
Sub-Industry | Brewers |
IPO / Inception | 1997-03-05 |
ABEV Stock Ratings
Growth Rating | 10.3% |
Fundamental | 85.9% |
Dividend Rating | 62.3% |
Return 12m vs S&P 500 | -11.0% |
Analyst Rating | 3.42 of 5 |
ABEV Dividends
Dividend Yield 12m | 8.16% |
Yield on Cost 5y | 9.67% |
Annual Growth 5y | 8.13% |
Payout Consistency | 80.6% |
Payout Ratio | 56.2% |
ABEV Growth Ratios
Growth Correlation 3m | -32.2% |
Growth Correlation 12m | 59.7% |
Growth Correlation 5y | -26.5% |
CAGR 5y | -1.78% |
CAGR/Max DD 3y (Calmar Ratio) | -0.05 |
CAGR/Mean DD 3y (Pain Ratio) | -0.10 |
Sharpe Ratio 12m | -0.15 |
Alpha | -6.22 |
Beta | 0.342 |
Volatility | 23.45% |
Current Volume | 30098.3k |
Average Volume 20d | 42572.9k |
Stop Loss | 2.1 (-3.2%) |
Signal | 0.05 |
Piotroski VR‑10 (Strict, 0-10) 8.0
Net Income (14.75b TTM) > 0 and > 6% of Revenue (6% = 5.50b TTM) |
FCFTA 0.15 (>2.0%) and ΔFCFTA 1.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 4.27% (prev 4.57%; Δ -0.30pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.18 (>3.0%) and CFO 26.28b > Net Income 14.75b (YES >=105%, WARN >=100%) |
Net Debt (-13.25b) to EBITDA (27.03b) ratio: -0.49 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (15.74b) change vs 12m ago -0.45% (target <= -2.0% for YES) |
Gross Margin 51.50% (prev 49.56%; Δ 1.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 64.23% (prev 56.40%; Δ 7.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 9.30 (EBITDA TTM 27.03b / Interest Expense TTM 2.36b) >= 6 (WARN >= 3) |
Altman Z'' 4.95
(A) 0.03 = (Total Current Assets 40.79b - Total Current Liabilities 36.87b) / Total Assets 142.16b |
(B) 0.03 = Retained Earnings (Balance) 4.32b / Total Assets 142.16b |
(C) 0.15 = EBIT TTM 21.91b / Avg Total Assets 142.80b |
(D) 3.46 = Book Value of Equity 169.41b / Total Liabilities 48.95b |
Total Rating: 4.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.89
1. Piotroski 8.0pt = 3.0 |
2. FCF Yield 12.54% = 5.0 |
3. FCF Margin 23.61% = 5.90 |
4. Debt/Equity 0.03 = 2.50 |
5. Debt/Ebitda -0.49 = 2.50 |
6. ROIC - WACC (= 10.75)% = 12.50 |
7. RoE 15.38% = 1.28 |
8. Rev. Trend 30.90% = 2.32 |
9. EPS Trend 17.86% = 0.89 |
What is the price of ABEV shares?
Over the past week, the price has changed by +0.00%, over one month by -6.87%, over three months by -6.71% and over the past year by +3.41%.
Is Ambev a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ABEV is around 2.14 USD . This means that ABEV is currently overvalued and has a potential downside of -1.38%.
Is ABEV a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ABEV price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 2.8 | 30.9% |
Analysts Target Price | 2.8 | 30.9% |
ValueRay Target Price | 2.4 | 8.8% |
Last update: 2025-10-13 02:03
ABEV Fundamental Data Overview
P/E Trailing = 12.4118
P/E Forward = 11.0011
P/S = 0.3732
P/B = 1.9654
P/EG = 1.1455
Beta = 0.342
Revenue TTM = 91.72b BRL
EBIT TTM = 21.91b BRL
EBITDA TTM = 27.03b BRL
Long Term Debt = 2.06b BRL (from longTermDebt, last quarter)
Short Term Debt = 1.10b BRL (from shortTermDebt, last quarter)
Debt = 3.16b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = -13.25b BRL (from netDebt column, last quarter)
Enterprise Value = 172.75b BRL (187.11b + Debt 3.16b - CCE 17.52b)
Interest Coverage Ratio = 9.30 (Ebit TTM 21.91b / Interest Expense TTM 2.36b)
FCF Yield = 12.54% (FCF TTM 21.66b / Enterprise Value 172.75b)
FCF Margin = 23.61% (FCF TTM 21.66b / Revenue TTM 91.72b)
Net Margin = 16.08% (Net Income TTM 14.75b / Revenue TTM 91.72b)
Gross Margin = 51.50% ((Revenue TTM 91.72b - Cost of Revenue TTM 44.49b) / Revenue TTM)
Gross Margin QoQ = 50.00% (prev 51.35%)
Tobins Q-Ratio = 1.22 (Enterprise Value 172.75b / Total Assets 142.16b)
Interest Expense / Debt = 17.98% (Interest Expense 567.9m / Debt 3.16b)
Taxrate = 18.40% (629.1m / 3.42b)
NOPAT = 17.88b (EBIT 21.91b * (1 - 18.40%))
Current Ratio = 1.11 (Total Current Assets 40.79b / Total Current Liabilities 36.87b)
Debt / Equity = 0.03 (Debt 3.16b / totalStockholderEquity, last quarter 92.47b)
Debt / EBITDA = -0.49 (Net Debt -13.25b / EBITDA 27.03b)
Debt / FCF = -0.61 (Net Debt -13.25b / FCF TTM 21.66b)
Total Stockholder Equity = 95.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.38% (Net Income 14.75b / Total Assets 142.16b)
RoE = 15.38% (Net Income TTM 14.75b / Total Stockholder Equity 95.95b)
RoCE = 22.36% (EBIT 21.91b / Capital Employed (Equity 95.95b + L.T.Debt 2.06b))
RoIC = 18.15% (NOPAT 17.88b / Invested Capital 98.51b)
WACC = 7.40% (E(187.11b)/V(190.27b) * Re(7.28%) + D(3.16b)/V(190.27b) * Rd(17.98%) * (1-Tc(0.18)))
Discount Rate = 7.28% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.29%
[DCF Debug] Terminal Value 79.64% ; FCFE base≈21.13b ; Y1≈23.30b ; Y5≈30.03b
Fair Price DCF = 33.49 (DCF Value 522.22b / Shares Outstanding 15.59b; 5y FCF grow 11.74% → 3.0% )
EPS Correlation: 17.86 | EPS CAGR: -61.77% | SUE: -0.82 | # QB: 0
Revenue Correlation: 30.90 | Revenue CAGR: -0.89% | SUE: -0.06 | # QB: 0
Additional Sources for ABEV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle